ImmunoPrecise Antibodies Total Long Term Liabilities 2022-2024 | IPA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

ImmunoPrecise Antibodies total long term liabilities from 2022 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

ImmunoPrecise Antibodies Total Long Term Liabilities 2022-2024 | IPA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

ImmunoPrecise Antibodies total long term liabilities from 2022 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$8.5B
Inspire Medical Systems (INSP)	$5.3B
Hims & Hers Health (HIMS)	$5.1B
Privia Health (PRVA)	$2.5B
Enovis (ENOV)	$2.5B
IRhythm Technologies (IRTC)	$2.4B
Azenta (AZTA)	$2B
Omnicell (OMCL)	$2B
Clover Health Investments (CLOV)	$1.6B
10x Genomics (TXG)	$1.6B
Schrodinger (SDGR)	$1.4B
Phreesia (PHR)	$1.1B
Butterfly Network (BFLY)	$650M
Standard BioTools (LAB)	$562M
Talkspace (TALK)	$522M
Fulgent Genetics (FLGT)	$520M
Definitive Healthcare (DH)	$483M
Health Catalyst (HCAT)	$459M
TruBridge (TBRG)	$244M
Pulmonx (LUNG)	$237M
SOPHiA GENETICS SA (SOPH)	$214M
American Well (AMWL)	$122M
EUDA Health Holdings (EUDA)	$107M
P3 Health Partners (PIII)	$75M
HeartBeam (BEAT)	$67M
111 (YI)	$53M
CareCloud (CCLD)	$46M
Zepp Health (ZEPP)	$40M
SHL Telemedicine (SHLT)	$40M
Outset Medical (OM)	$39M